AI-generated summary
The authors report a randomised controlled trial of 60 patients after third molar extraction, comparing dual-wavelength photobiomodulation with amoxicillin given for 3 or 7 days and no adjunctive therapy. They report that photobiomodulation reduced loss of mouth opening and the sensation of pain and oedema, while antibiotics showed no difference from the control group.
- Participants
- 60
- Who or what was studied
- Sixty patients undergoing extraction of all four third molars in one session, randomly allocated to four groups of 15.
- Wavelengths
- 660, 808 nm
- Limits stated in the abstract
- The abstract does not report the group sizes beyond n = 15 per group, the outcome measures' statistical details, or the length of follow-up beyond 90 days.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm, 808 nm
- Power
- 200 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Visual analogue scale, Inflammation, Trial registration, Wavelength. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.